{"name":"BTG International Inc.","slug":"btg-international-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2012-01-01","label":"Voraxaze first approved","drug":"Voraxaze","drugSlug":"glucarpidase","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Voraxaze","genericName":"GLUCARPIDASE","slug":"glucarpidase","indication":"Toxic plasma methotrexate concentration reduction","status":"marketed"}]}],"pipeline":[{"name":"Voraxaze","genericName":"GLUCARPIDASE","slug":"glucarpidase","phase":"marketed","mechanism":"Voraxaze works by breaking down the chemotherapy medication methotrexate into a less toxic form.","indications":["Toxic plasma methotrexate concentration reduction"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE92WV9EYVVKQ3REV1oxYXBubm5QNHpYbzdtOVFaaGkxbXRORnIzaVNrNW02NDV3SV9wYURWSFUxdFYxZ2dyU0NpUFZYeUc4ZGlfSHFoaFhERkQ2UENWSC1NWUI2Mk1UbTlo?oc=5","date":"2025-11-09","type":"pipeline","source":"MedPage Today","summary":"Investigational Combination Shows Promise in Chronic Hepatitis D - MedPage Today","headline":"Investigational Combination Shows Promise in Chronic Hepatitis D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOcE85TW9JWHd5dGVHdFBSVEpGRHl4RVd6bERVSUQyUFcxUlViaHFZaGQwVG9Kb3llMDhFVDE3WGQxLTk5RFRCa3M1UTBOMGpyY0JMYVpZZWdTLUhxc0kzUFdyVUdYaGpPWmpJNmVvNFIxdjduemtwNDdCNXNqVFNQNEJEWjF5NVVuUGxFQjZtLTcwUW9NRndOdVM3TjZLdk9fQm5YYmxuV3I0eDdiRFVfVGMtWU5nVE4zd0RPaHhpcnhIR2R2S19XVjBqU1l4aGMyVDQ4cFFBUXBlYmJMTWoycnM1X1RTaGM?oc=5","date":"2025-06-09","type":"deal","source":"Reuters","summary":"Exclusive: UnitedHealth eyes $1 billion deal to exit Latin America as insurer refocuses on US, sources say - Reuters","headline":"Exclusive: UnitedHealth eyes $1 billion deal to exit Latin America as insurer refocuses on US, sources say","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxObWpKQzgyTVhBd1V6M0pOX2pqQ0VmVS1zSGVETGdqRGlsTU5iN0pwaTNkcm9yQ3dremszc0RLNDdnNTRRQnd2OVdGOVhraTBxYVlpbmpNb3F6NmJDejNlWEYyZnlfMDFNd2xxaDlPcHkzb3dPTGw0ZHA1M2JVOUpnR0JSOXlLeUNrcWFVZUp0Tlo1aUpnOHM1d3JYdFRWQ2d0d1liNlAxb002ZFp2RVVKT1RYTUxQLWJMU3QtbUlBbVRpTXAwRmdRWVFyX29JUEZDSml6QzhDNElIanJWZUZqQ3ZhN3k?oc=5","date":"2025-01-10","type":"pipeline","source":"Specialty Pharmacy Continuum","summary":"Glucarpidase Boosts Recovery From Methotrexate-Induced Acute Kidney Injury - Specialty Pharmacy Continuum","headline":"Glucarpidase Boosts Recovery From Methotrexate-Induced Acute Kidney Injury","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPeWxwQXhOa0pBRmItRlNUMmxCYXhRZGxMQkhEbUhaREpUQW5NdmdVLUR3OEZ1UzNIUWd2QjlwRG9kVU0wdFlGZXFvaE9ZU3VvX0xIaEdvRzk3clV6bi0yNU9oNktuZ1ZYeVlYaDVUd1k0a3BPNHhSOUlEVHRzY2dwNTRXekdzRkF1cTNQaVc3UGJFUHVWLVc1RTIyRmhYZmZla0luNFZmQWFJQldhcnZ6MEZ2V0FpZHhPVWppdGZSam1NelFBbkgwbl9YeXVwVmM?oc=5","date":"2025-01-08","type":"pipeline","source":"Business Wire","summary":"Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer - Business Wire","headline":"Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPXzk2QVBsVTFIWWllZGJkY1ZDQ3ZEVndmRkpvXzktSnhVelg2UkZ0eEh1ZjcteVRHalhrU2JVOFlVNzRMcDdaeU9TU0lsX2xsVVVSV2FkYlotOXl2NElXdTladzI2ekpqWDlVQm01NjR5YUdQM1RiVGNXMVdfVVlPQnBXbU00WVd1OWFkajQzcDRBdnNhT2VUYnZZWUM5Sm1UaHoxUnNpNks1NDlkaTA1SHdXVy1nbmpRU3k3RW5MOHZBSnhyOXp4SlBzMGJCbDlWUTZESW1EdmJIODZmMkE?oc=5","date":"2023-11-13","type":"deal","source":"respiratory-therapy.com","summary":"PneumRx Acquired by BTG for up to $475M - respiratory-therapy.com","headline":"PneumRx Acquired by BTG for up to $475M - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxNbXFHSFNTeUNRLXQ2OXJxdGJ6ZTczaEE1NEw5NllocmIweUpwTFVYMlN6bFExRTM3dkhTcFY0eE9WcUNTZXZiVEFCWlV5Z2daZTNBanFGTmotcTVmYjFFeXFuWnZkWkVIT05BWGo1eTB4SXIxc0laWEtLTW9jLWJnSnFmanZoZXFXU2VnOFZYTlVsR1RhZm13YlE1U0dsMkFObko5NWNWVHFfWlVpNjBfV2tmVUV2SjB4SEdnYVFxdFd3b0JrQXFld0JsbkpGT0x0d1FUTFFZYTNzVHlXb2J5Z2lweldLQkI4RUVSSGd6Smt0dGpYcDUyZGhBbFdXUWlaSHRmX0pkTnRSaTVsM2ZjQTJJR0JXSlM5YTh0TS1Ha0lVY2Fyd01yaGZIaDYxdmd4eGJqTmZQdFRCNmlI?oc=5","date":"2023-09-21","type":"trial","source":"GlobeNewswire","summary":"BTG Pharmaceuticals, a SERB company, to present data on - GlobeNewswire","headline":"BTG Pharmaceuticals, a SERB company, to present data on","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQU3ZJV0x0dHZCamlqbjduYnlfaWpzUTM0ZkI4ZjJDeFFmUlNpUHhWWS1Ea0QwUE1PLWRqdnE0LVMtalZrTUN0c1JWZS1kY2NRbWtkOXdrUFhCbVhwZDd1WlFtdGxWSkozRjBCQlRqNGxLTEJFSUQ4b1BVZmx6TG1jeUVHcV9LMTB4cnRwYWdWQmhqTFBRQldKRmhlMXNKSi1aTm9uUGtSZjdsN2pUcm0wc0oxcUw3NnNCNHVzbkRRbjFyYVlTMzRONFJLUnFBbHUzc0hzb044QmlKclJWd1AxRTJJcEtyTHBJVVJsbS1Qa0xTSUxhSUVJRHpSSWs?oc=5","date":"2021-03-02","type":"pipeline","source":"PR Newswire","summary":"SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines - PR Newswire","headline":"SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQV1prV252YUhSRlE2NEZQQXFFVV9kZy1aQXlBVXdOS1QySVAta0ZXVEVOY3lMWTk5OFB3VjU3UlQ5QTRfN1V6TDJIVU1hU0JlRFpjT2JRaWF0Y3FvZG9lOXE3ZVU5S0xLeHR1eHRXdW90VWlrbTFlQnZjR2J4ay1wOVFZd0RJUjItdXo0M1oxT295Y25qX3JPMWNkZFZkR3ZfbUt5SG80X0Rxdw?oc=5","date":"2021-03-02","type":"deal","source":"MassDevice","summary":"Boston Scientific completes Preventice buy, divests BTG Pharmaceutical business - MassDevice","headline":"Boston Scientific completes Preventice buy, divests BTG Pharmaceutical business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOM3BjMkRvWTFzY1ZvajR6VFU0MTlQUWYwOGV2ZjcwdzhsWUs3QjFhcEpKR3p6SnNfaC1rUkxTSnVHdDc3bTdiYTFsekZUcUZad21fdjZ3Vk5jS3JJVTd5OU5YMFZKR0dpSFlVVlJ0cGxRai0yMWMyTS1BQ2FXOHhPOTB3T2tQTGtFSTdaaEhqU2d3cXQ2ZGF3SGtYYzFORFJKV0hON1Rn?oc=5","date":"2020-12-02","type":"pipeline","source":"Citeline News & Insights","summary":"SERB Pays $800m For Boston Scientific Specialty Pharma Business - Citeline News & Insights","headline":"SERB Pays $800m For Boston Scientific Specialty Pharma Business - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOOEFyZ3I0cTVFYUswX2hNVHNONXRzTmNYRXdXZkR3TzYwODRnYzlkRmR3RWpSUjJCLThwUkZZNWxscFZSWWZBa2RJbTVWOERfZFpRdk9oeWhSbjRmNGRXdUtpejdJcU1peWNrQjlEb1VsYjN6bGZiTjZXQW9WcTRmdERjY0pYQUxLb3ZuZThIZFBCdEQ3ckJCUUN6M2pwRmdTSXJzNnRHVDE1T0NLVWZPM3VjTWoyQ2hxN2h2RmtScGZYbVgtRE9uNW9Tc0NhTU80eElPb04zOU9HWUI2aGJuY3dEWQ?oc=5","date":"2020-12-01","type":"pipeline","source":"PR Newswire","summary":"Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business - PR Newswire","headline":"Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxORmgyRURxQV9ocWFUYnAzOVYydFE4NXhLazRnc3JOVDU5MXFRX090eDhSS0RuN2tNay10WUZDVURoRFdLUHVvWllEMDEyTTlfNjlLX2NPXzAxUnNYU3RoNkQ4c3NLWWdQVmZQNWtRbnpxa3R6bl9iWDRSMWlEdmxhMWhHMHhrczhUMExpRA?oc=5","date":"2019-08-19","type":"pipeline","source":"MedTech Dive","summary":"Boston Scientific closes acquisition of BTG - MedTech Dive","headline":"Boston Scientific closes acquisition of BTG","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNWktzUXlObnhoYjljX0tENjNVVjlpSS1KVXlhbmdhZFRxX0V5SDE5SVB1ZTAybDhmOGlTaXV2V0ZzcnNTcHd5cG5ZMTNTTDdKTzN3d0J5aTNkXzZzZjl4cVUtM2w2UUZTNEszcDNPaWNaR0ZMMWI2RkpkMEo4YVNoaTI2Qml2Rng1VnlZczdLR1BjNGs5c1ZB?oc=5","date":"2018-11-21","type":"deal","source":"Medical Device Network","summary":"Boston Scientific to acquire BTG in $4.2bn deal - Medical Device Network","headline":"Boston Scientific to acquire BTG in $4.2bn deal","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}